Cargando…
Synthesis and Molecular Docking of Some Novel 3-Thiazolyl-Coumarins as Inhibitors of VEGFR-2 Kinase
One crucial strategy for the treatment of breast cancer involves focusing on the Vascular Endothelial Growth Factor Receptor (VEGFR-2) signaling system. Consequently, the development of new (VEGFR-2) inhibitors is of the utmost importance. In this study, novel 3-thiazolhydrazinylcoumarins were desig...
Autores principales: | Abolibda, Tariq Z., Fathalla, Maher, Farag, Basant, Zaki, Magdi E. A., Gomha, Sobhi M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9861390/ https://www.ncbi.nlm.nih.gov/pubmed/36677750 http://dx.doi.org/10.3390/molecules28020689 |
Ejemplares similares
-
Mechanochemical Synthesis and Molecular Docking Studies of New Azines Bearing Indole as Anticancer Agents
por: Ibrahim, Mohamed S., et al.
Publicado: (2023) -
Design, efficient synthesis and molecular docking of some novel thiazolyl-pyrazole derivatives as anticancer agents
por: Sayed, Abdelwahed R., et al.
Publicado: (2019) -
Synthesis, In Vitro Evaluation and Molecular Docking Studies of Novel Thiophenyl Thiazolyl-Pyridine Hybrids as Potential Anticancer Agents
por: Ashmawy, Fayza O., et al.
Publicado: (2023) -
Synthesis, Biological
Evaluation, and Molecular Docking
of Novel Azolylhydrazonothiazoles as Potential Anticancer Agents
por: Al-Humaidi, Jehan Y., et al.
Publicado: (2023) -
Synthesis, Characterization and Molecular Docking of Novel Bioactive Thiazolyl-Thiazole Derivatives as Promising Cytotoxic Antitumor Drug
por: Gomha, Sobhi M., et al.
Publicado: (2015)